HRC Speakers

Alex Mata has developed a 27-year career in the healthcare industry, beginning in the pharmaceutical sector and later transitioning to healthcare services and technology. He is a pharmacist and holds an MBA from ESADE Business School as well as a PDG from IESE. Alex currently serves as Senior Vice President of Operations and Product Development for Teladoc Health's international business.

Neuróloga especializada en enfermedades inflamatorias del sistema nervioso central y Coordinadora de la Unidad de Neurología Autoinmune en el Hospital de la Santa Creu i Sant Pau. Su investigación se ha centrado en la esclerosis múltiple (EM), el estudio de la vía visual como modelo de neurodegeneración y la identificación de biomarcadores con valor diagnóstico y pronóstico. Tras desarrollar su trayectoria en un centro de referencia internacional (Cemcat, Hospital Vall d’Hebron), actualmente lidera un grupo de investigación emergente en el Institut de Recerca del Hospital de la Santa Creu i Sant Pau, con el objetivo de consolidar una línea de investigación estable en neurología autoinmune y biomarcadores en patologías del SNC. Su experiencia en el liderazgo de proyectos competitivos, su participación en redes internacionales y su contribución al desarrollo de los nuevos criterios diagnósticos de la EM refuerzan su trayectoria en este campo. En ese sentido, ha sido investigadora principal de dos proyectos financiados por el Instituto de Salud Carlos III: PI22/01589 y PI17/02162, que han permitido estudiar la vía visual desde las fases iniciales de la EM y han generado resultados clave en el ámbito del diagnóstico precoz y los resultados han sido incorporados en la nueva revisión de los criterios diagnósticos.

Barry brings with him seven years’ experience as a Biomedical Engineer and Sr. Scientific Reviewer at FDA/CDRH/ODE and FDA’s Boston District. This government experience was followed with over 17 years in midlevel and executive management positions in small start-up/large multinational medical device companies.  Market responsibilities included United States, EU, South America, Canada, Japan and South Korea. Barry has extensive experience with product development and FDA negotiations of US regulatory strategy (EUA, DeNovo 510(k) with clinical data, Breakthrough Designation, etc.). In the area of diagnostics this experience includes diagnostic devices for COVID-19, diagnostics using biomarkers in sweat, diagnostics using breath (diabetes and lung cancer), measurement of radiation exposure, and diagnosis of stroke.  He has written multiple 510(k)s, IDEs, and PMAs in cardiovascular,  orthopedic/sports medicine, spine, general surgery, gastroenterology, neurology/neurosurgery, and Ob/Gyn. Technologies embedded in these products included Machine Learning/AI, 3D Printing, and Software.

MHS Europe Special Operation Manager for TÜV SÜD group, for onboarding of new clients under MDR, IVDR and all other schemes related to medical devices. Lead Auditor and Technical Documentation Assessor for MDR Regulation (EU) 745/2017. Carlo Gherardi holds a MSc in chemistry. He joined TÜV Italia (TÜV SÜD Italian subsidiary) in 2004 as Lead Auditor and Technical Documentation Assessor for non active medical devices. Previously, he had 10 years of professional experience in the design and development and quality assurance of sterile non active medical devices in the medical devices industry. As Lead Auditor, Project Handler and Technical Documentation assessor, Carlo is actively driving MDR (EU) Regulation 2017/745 conformity assessment activities in Italy and internationally as well as MDSAP, ISO 13485 and other regulatory schemes.

Carlos is a graduate in Leadership, Entrepreneurship and Innovation from the University of Mondragon. He has six years of professional experience in the management of digital business projects, through his career he founded of a digitalization and innovation consultancy named MAKNAD (2017 - 2020) that operated internationally working in San Francisco and Paris. Thanks to his education and professional experience, Carlos has diverse knowledge and skills in project management, growth strategies, funding, business strategy and digital marketing.

In december 2020 he founded TRAK, an AI powered digital physiotherapy medical software.

Naturally curious and passionate about science, I hold a PhD in Biomedicine with a strong background in Immunology. My academic journey has shaped me into a proactive team player, experienced in multidisciplinary collaboration across research, healthcare, and the pharmaceutical industry. Over the last years, I have honed my analytical thinking, problem-solving, and project management skills. Currently, I am focused on contributing to acute stroke management through my work at ABCDx, helping bring innovative diagnostic solutions closer to clinical practice to improve patient outcomes. I value commitment, organization, and teamwork as the foundation of my professional approach.

CEO & Founder CMG MedDev

Cathyana Marcel: Head of Advocacy and Lead Teaching Artist
Cathyana Marcel is an educator, college life coach, and head of advocacy for the Kevin Love Fund. With a master’s degree in social work from Florida International University and a bachelor’s degree in psychology from Lee University, Cathyana brings a wealth of knowledge and experience to her roles. Her background in training and development, higher education, and the nonprofit sector has allowed her to engage with individuals in transformative ways, fostering environments where participants are empowered to step into their stories. In reflecting on her experience delivering this curriculum she shares, “Living in a culture that caters too easily to silencing our inner struggles, the Kevin Love Fund project was life-giving and empowering for our students.” Cathyana is a lover of stories, leadership development, and creating brave spaces that empower individuals to become their best selves.

Celin Mousa co-founded MCS Data Labs to turn complex health data into clear, accessible insights—making health tech adaptable to users’ needs.

Mediktor is the most accurate AI based medical chatbot for triage and prediagnosis.

President of Barcelona Health Hub

BHH is a nonprofit private association created to promote innovation in digital health and its transfer to the sector, linking startups, health organizations, companies and investors.

Member of the Board at Antai Venture Builder & Member of Antai Business Angels.

Angel investor in more than 20 Startups.

2015-2016 General Manager at Eurekaparts.com

The largest Spanish online company with a full range of garden equipment and spare parts and accessories.

20 years of experience in management.

From 1998 to 2015 holding different management positions in Europastry, the leading frozen Bread&Pastry manufacturer in Spain and Portugal. Helping the company to rise from 30 to more than 400 Millions € of turnover.

From 1996, Member of the Board in Greens Power Products, the exclusive Honda Power Products distributor for Spain. Greens has led the Agricultural, Garden and Marine power products sector since 1978.

Daniele Lezzi has a Ph.D on Computer Engineer from University of Lecce. Since 2008, he has been a researcher at the Barcelona Supercomputing Center (BSC), a world-renowned research center specializing in high-performance computing and data analysis, home to MareNostrum5, one of the world's most powerful supercomputers, within a European supercomputing collaboration that includes, among others, LEONARDO at CINECA.

David's current position is Director of the Digital Health R&D group at Fundació Eurecat. He holds an MSc in Electronics (URL, Barcelona), an MSc in Telecommunications (URL, Barcelona) and has a Master in Business Administration (MBA) from UPF, Barcelona.

He has over 15 years of experience in project and R&D management with interdisciplinary teams, working with both industry and academia, and participating in EU Framework programme projects since 2011. He has always been involved in projects regarding digital technologies, working in a range of various sectors like media companies, social services in the public sector, start-ups, consultancy and project management in the energy and healthcare sectors.

Diana Heinrichs, CEO and founder of LINDERA, is specialized in AI-based 3D-motion analysis for MedTech and elder care applications. By combining medical knowledge and AI, LINDERA has succeeded in generating precise gait parameters using the simple smartphone-camera. For the medical device manufacturer, there are many use cases, fall prevention in age is one of them. Before LINDERA, Diana worked for Microsoft. She studied linguistics at the interface with psychology at the Universities of Bonn, Florence and Oxford and completed an MBA at the University of St. Gallen.

Passionate about the potential of artificial intelligence to transform healthcare. Our goal is to provide innovative solutions that improve the health system in a human, efficient, sustainable and safe way.

Licenciado en Medicina y Cirugía por la Universidad de Navarra 1998.
Formación en Oftalmología MIR en el Hospital Vall d’Hebrón (1999-2003).
Director de la Unidad de Retina y Vítreo desde 2005.
 Miembro de la Unidad de Traumatología Ocular desde 2003. Jefe Clínico/ Cap Clínic del Servicio de Oftatalmología del Hospital de Sant Pau, Barcelona desde 2017. Médico Consultor de la Unidad de Retina y Vítreo de la Unidad de Uveítis del Servicio de Oftalmología del Hospital de Sant Pau, Barcelona desde 2005.

Elisenda Bonet-Carne is a researcher specialized in medical image processing and technology transfer to clinical practice, with a primary focus on fetal and perinatal medicine.

Ellie Foster, PhD is the Co-Director of Education for the Kevin Love Fund. Ellie holds a master’s of science degree in educational psychology from University of Wisconsin-Madison and a PhD in literacy education from University of Colorado at Boulder. Ellie is an advocate for centering creativity, storytelling, and emotional expression in the way schools approach social-emotional learning and trauma sensitive practices. Ellie has supported this approach as a literacy researcher, k-12 teacher educator, high school English teacher, and as an activist for youth experiencing homelessness.

I am a consultant hematologist and head of the inpatient hematology unit at Hospital El Bierzo, Spain. My clinical focus is on improving patient outcomes through innovation and multidisciplinary collaboration. In recent years, I have been leading the development of advanced home-based treatment programs for hematology patients, making Hospital El Bierzo a national reference in this field. Our initiative enables patients to receive complex therapies safely at home, supported by telemedicine, home visits, and coordinated pharmaceutical care. This approach enhances equity, quality of life, and resource efficiency, especially for patients in rural or remote areas. I share insights on these advances and digital health transformation on Twitter (@erikbierzo) and LinkedIn (Erik de Cabo López)

Eva García Ramos, CEO & Co-founder of WIVI VISION. PDG from IESE, Telecommunications Engineer. She has served as Global Director of Applications at Gamesa Siemens and as a member of the executive committee in various companies across different sectors. With over 25 years of experience in management, technological solutions, and vision sciences, she has led teams of more than 120 people and managed large-scale budgets. In 2023, she was recognized as a Forbes Changemaker, and in 2024, she was named one of the 35 leading Spanish women in technology by Forbes Women Spain. She also won the 2024 Dona TIC Award in the Businesswoman category. In 2025, WIVI VISION was highlighted by Forbes as a standout company.

Eva is CEO at Barcelona Health Hub. She connects the members of the digital health ecosystem while promoting the BHH brand in Barcelona and beyond. Before her journey at BHH started, she worked in different sectors, such as Atrapalo.com, LetsBonus, Tech Barcelona and Shiseido. 

Thirty years of experience in top management positions in multinational companies such as ATT, Texaco, McDonald's. International executive coach in Spain and Latin America. Published 7 management books. Expert in innovation, construction of innovative ecosystems. Innovation counselor.

Passionate about pharmaceutical marketing and sales, understanding it as a vehicle to improve people's health. Proven success in the positioning and repositioning of products with significant sales growth. Strong strategic vision. Quick decision-making in complex situations. Skilled at identifying new business opportunities. Ability to turn around challenging client situations. Expert in Marketing and Sales in the pharmaceutical market, both nationally and internationally.

Gemma is an entrepreneurial IT leader with over twenty years of experience in sales, innovation, and business management, spanning AI, IoT, Blockchain, Security, and e-health technologies. Her goal is to drive rapid growth through innovation, talent attraction, and the leadership of high-performance teams. She has a strong track record in developing innovative and collaborative projects with multinational companies, SMEs, and technology-based entrepreneurs.

Inma Rodríguez is Market Intelligence Manager at ACCIÓ. Belonging to the Ministry of Business and Labour of the Government of Catalonia, ACCIÓ is the agency for business competitiveness.

Más de cinco años de experiencia en gestión de proyectos de transformación digital, liderando iniciativas estratégicas en Sanitas Seguros. He coordinado el lanzamiento de productos y servicios digitales a nivel nacional e internacional. Mi trabajo diario combina visión estratégica, innovación y ejecución, con experiencia en internacionalización y adaptación de servicios a nuevos mercados. Anteriormente, en Sanitas Dental, trabajé en mejorar la experiencia del cliente. Soy graduada en ADE con especialización en comercio internacional y poseo un máster en Asuntos Internacionales por ICADE y Georgetown University.

Isabel López Guerrero is the founder and CEO of EpisKey Medical Consulting, a Spanish firm specializing in regulatory strategy for innovative health technologies. She has over 15 years of experience in the pharmaceutical and medical device industries. Isabel advises digital health companies on regulatory compliance, including cybersecurity and AI integration, aligning innovation with MDR and international standards. Isabel is a frequent speaker on digital transformation, ethics in AI, and global healthtech regulation.